Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.775 USD | +3.55% | -4.21% | -2.68% |
May. 02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.68% | 1.28B | |
+23.83% | 44.96B | |
+0.30% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.67% | 26.08B | |
-21.15% | 19.03B | |
+6.76% | 12.75B | |
+29.23% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- BofA Securities Downgrades Vir Biotechnology to Neutral From Buy, Cuts Price Target to $14 From $23 After Shares Underperformance